What should J&J’ers do now?
December 14, 2021 Leave a comment
That’s definitely a question I’ve had for a long time. I think as much as anything the much, much more rare status of J&J people has led us to be largely ignored (or at least belatedly paid attention to) in a lot of public health guidance, and to my display, led to far too little scientific discussion among all the science types I follow on twitter.
Finally, I found somebody on the case. Stanford MD/PhD Michael Lin has been one of my best twitter finds of recent months and I love that in this great thread he actually gets nicely explicit on what all the latest findings on Omicron mean for J&J folks. Whole thread is quite interesting, but here’s the key upshot:
Also, my physician said he’d consider letting me have another mRNA regardless of CDC guidelines once the science shows the benefit. So, now that I’m writing this blog post I’ll at least know where to find this twitter thread to show him. Hopefully by the point I should get that booster, though, there will be something more than a twitter thread to show him.
Also, next semester I’ll be interacting with probably a fair number of people whose primary dose was J&J (NCSU was really pushing it on students last April due to the ease of just 1 dose and the fact that many would leave at the end of Spring semester before a 2nd dose), so, I really want them as boosted as possible, too.
Recent Comments